Article Versions Notes

Su J, Fang H, Lin Y, Yao Y, Liu Y, Zhong Y, Li X, Sun S, Huang B, Yang G, et al. 3,3′-Diindolylmethane Ameliorates Metabolism Dysfunction-Associated Fatty Liver Disease via AhR/p38 MAPK Signaling. Nutrients. 2025; 17(10):1681. https://doi.org/10.3390/nu17101681

Su, Jiewen, Heng Fang, Yunfeng Lin, Yilu Yao, Yanxi Liu, Yuquan Zhong, Xudong Li, Siyu Sun, Bing Huang, Guangyu Yang, and et al. 2025. "3,3′-Diindolylmethane Ameliorates Metabolism Dysfunction-Associated Fatty Liver Disease via AhR/p38 MAPK Signaling" Nutrients 17, no. 10: 1681. https://doi.org/10.3390/nu17101681

Su, J., Fang, H., Lin, Y., Yao, Y., Liu, Y., Zhong, Y., Li, X., Sun, S., Huang, B., Yang, G., Li, W., Zhang, Y., Li, J., Wu, J., Liu, W., Hu, Q., & Zhu, W. (2025). 3,3′-Diindolylmethane Ameliorates Metabolism Dysfunction-Associated Fatty Liver Disease via AhR/p38 MAPK Signaling. Nutrients, 17(10), 1681. https://doi.org/10.3390/nu17101681